TRIPLE-NEGATIVE BREAST CARCINOMA
Clinical trials for TRIPLE-NEGATIVE BREAST CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new TRIPLE-NEGATIVE BREAST CARCINOMA trials appear
Sign up with your email to follow new studies for TRIPLE-NEGATIVE BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could cutting calories boost Radiation's power against breast cancer?
Disease control Recruiting nowThis study looks at whether eating fewer calories while getting focused radiation (SABR) before surgery can shrink breast tumors more than radiation alone. About 80 adults with early-stage breast cancer will be randomly assigned to one of two groups. The goal is to see if the com…
Matched conditions: TRIPLE-NEGATIVE BREAST CARCINOMA
Phase: NA • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated May 17, 2026 00:45 UTC
-
New drug combo shows promise in shrinking tough breast cancer before surgery
Disease control Recruiting nowThis study tests whether adding the drug darolutamide to standard chemotherapy and immunotherapy before surgery can shrink tumors more effectively in people with early-stage, androgen receptor positive triple-negative breast cancer. About 51 participants will receive either stand…
Matched conditions: TRIPLE-NEGATIVE BREAST CARCINOMA
Phase: PHASE2 • Sponsor: Vandana Abramson • Aim: Disease control
Last updated May 17, 2026 00:30 UTC
-
Breast cancer breakthrough: Surgery-Free option for exceptional responders?
Disease control Recruiting nowThis study is testing whether women with certain types of breast cancer (HER2-positive or triple-negative) who have no cancer left after initial drug therapy can safely skip surgery and just receive radiation. For others with ER-positive/HER2-negative cancer, it tests skipping ra…
Matched conditions: TRIPLE-NEGATIVE BREAST CARCINOMA
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
Tailor-Made cancer vaccine shows promise in advanced tumors
Disease control Recruiting nowThis study tests a personalized vaccine made from a patient's own tumor proteins, combined with the immunotherapy drug pembrolizumab, for people with advanced solid tumors. The goal is to see if this combination is safe and helps the immune system fight cancer more effectively. A…
Matched conditions: TRIPLE-NEGATIVE BREAST CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
Shorter radiation before breast surgery may cut side effects
Symptom relief Recruiting nowThis study compares giving a shorter course of radiation (hypofractionated radiotherapy) before versus after breast surgery for people with early-stage breast cancer that hasn't spread. The goal is to see if giving radiation before surgery reduces side effects and treatment time …
Matched conditions: TRIPLE-NEGATIVE BREAST CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated May 17, 2026 00:29 UTC
-
Stress relief program tested for triple negative breast cancer patients
Symptom relief Recruiting nowThis study tests whether a 10-week stress reduction program is doable and helpful for women with early-stage triple negative breast cancer. The program teaches relaxation, coping skills, and problem-solving, and also connects patients with social services for needs like transport…
Matched conditions: TRIPLE-NEGATIVE BREAST CARCINOMA
Phase: NA • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Symptom relief
Last updated May 15, 2026 11:57 UTC
-
Brain food: diet study aims to clear chemobrain in breast cancer patients
Symptom relief Recruiting nowThis study tests whether a 12-week MIND eating plan can ease memory problems, fatigue, and mood issues in 60 women with stage II-III triple-negative breast cancer during chemotherapy. Participants are randomly assigned to the MIND diet or general health coaching, with all session…
Matched conditions: TRIPLE-NEGATIVE BREAST CARCINOMA
Phase: NA • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Symptom relief
Last updated May 15, 2026 11:54 UTC
-
Talking computer aims to close genetic testing gap for cancer patients
Knowledge-focused Recruiting nowThis study tests whether a computer-generated character (called PERLA) can help cancer patients learn about genetic testing as well as a human counselor does. The goal is to make genetic testing easier to access for people who often miss out, like those in rural areas or who spea…
Matched conditions: TRIPLE-NEGATIVE BREAST CARCINOMA
Phase: NA • Sponsor: University of Southern California • Aim: Knowledge-focused
Last updated May 14, 2026 12:04 UTC